Michele Vincitore

1.1k total citations
18 papers, 841 citations indexed

About

Michele Vincitore is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Michele Vincitore has authored 18 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Michele Vincitore's work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Michele Vincitore is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Michele Vincitore collaborates with scholars based in United States and Israel. Michele Vincitore's co-authors include Matthew H. Kulke, Jeffrey W. Clark, Charles S. Fuchs, Ann Michelini, David P. Ryan, Peter C. Enzinger, Keith Stuart, Alona Muzikansky, Haesook Kim and Craig C. Earle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Michele Vincitore

18 papers receiving 823 citations

Peers

Countries citing papers authored by Michele Vincitore

Since Specialization

Citations

This map shows the geographic impact of Michele Vincitore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Vincitore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Vincitore more than expected).

Fields of papers citing papers by Michele Vincitore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Vincitore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Vincitore. The network helps show where Michele Vincitore may publish in the future.

Co-authorship network of co-authors of Michele Vincitore

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Vincitore. A scholar is included among the top collaborators of Michele Vincitore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Vincitore. Michele Vincitore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Title	Journal	Authors	Indexed citations
1	Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U.S. experience.	Journal of Clinical Oncology	Elizabeth Smyth, Peter C. Enzinger et al.	3
2	Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer	Annals of Oncology	Peter C. Enzinger, D. P. Ryan et al.	16
3	Selective Lymphopenia and Opportunistic Infections in Neuroendocrine Tumor Patients Receiving Temozolomide	Cancer Investigation	Elizabeth H. Stover, Ann Michelini et al.	54
4	A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs)	Journal of Clinical Oncology	Pankaj Bhargava, Andrew X. Zhu et al.	2
5	A Phase II Study of Doxorubicin, Cisplatin, and 5-Fluorouracil in Patients with Advanced Adenocarcinoma of the Stomach or Esophagus	Cancer Investigation	Matthew H. Kulke, Bingyan Wu et al.	8
6	Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors	Journal of Clinical Oncology	Matthew H. Kulke, Keith Stuart et al.	379
7	Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer	Journal of Clinical Oncology	Jeffrey A. Meyerhardt, Andrew X. Zhu et al.	81
8	A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma	Digestive Diseases and Sciences	Peter C. Enzinger, Matthew H. Kulke et al.	35
9	A Phase II Study of Docetaxel in Patients with Metastatic Carcinoid Tumors	Cancer Investigation	Matthew H. Kulke, Haesook Kim et al.	44
10	A Phase II trial of gemcitabine for metastatic neuroendocrine tumors	Cancer	Matthew H. Kulke, Haesook Kim et al.	56
11	Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC)	Journal of Clinical Oncology	J. A. Meyerhardt, Peter C. Enzinger et al.	2
12	Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer	Journal of Clinical Oncology	Peter C. Enzinger, Joseph I. Clark et al.	1
13	Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer	Journal of Clinical Oncology	Peter C. Enzinger, Jeffrey W. Clark et al.	6
14	Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC)	Journal of Clinical Oncology	J. A. Meyerhardt, Peter C. Enzinger et al.	7
15	A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma	Cancer	Charles S. Fuchs, Jeffrey W. Clark et al.	68
16	Prenatal protein malnourished rats show changes in sleep/wake behavior as adults	Journal of Sleep Research	Subimal Datta, Elissa H. Patterson et al.	35
17	Chlordiazepoxide-Induced Spatial Learning Deficits	Pharmacology Biochemistry and Behavior	John Tonkiss, Penny L. Shultz et al.	24
18	Prenatally protein-malnourished rats are less sensitive to the amnestic effects of medial septal infusions of chlordiazepoxide	Behavioural Pharmacology	John Tonkiss, Monika Trzcińska et al.	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact